Edwards Lifesciences EW Cash Flow Statement (2009-2026)

NYSE EW
$105.81 +1.79 (+1.72%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Edwards Lifesciences Quarterly Cash Flow Statement

Periods 71 quarters
Latest Sep 2026

Edwards Lifesciences reported cash from operations of $570.30M and free cash flow of $506.70M for the quarter ended Sep 2026, down 0.6% year over year. This cash flow statement covers 71 quarters of results from Mar 2009 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
335.30M373.60M406.40M343.50M398.40M340.50M307.10M384.90M369.90M351.00M365.00M3,070.80M385.60M356.40M331.50M291.10M91.20M380.70M241.40M307.50M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
33.00M34.70M34.10M35.40M35.40M35.20M36.10M36.90M36.70M38.50M39.60M34.50M42.60M36.60M38.10M39.20M42.70M40.90M42.70M44.90M
Share-based CompensationStock Comp.
24.20M32.40M36.20M30.30M27.90M38.90M37.40M32.60M30.50M44.60M43.90M42.10M31.70M40.20M37.50M41.20M39.20M45.40M42.20M46.00M
Deferred Taxes
-61.50M-42.60M-59.80M-46.30M-105.80M-51.80M-82.90M-46.00M-91.40M-35.80M-66.10M-123.00M-98.50M-24.30M-20.90M-18.00M-54.40M9.40M181.30M-60.60M
Gains from Sales and DivestituresGains Divest
10.80M33.90M
Gains from Investment SecuritiesGains Investment
11.20M-10.90M-2.40M-3.50M1.00M24.60M-12.50M12.50M-6.40M6.40M65.20M19.90M
Asset Writedowns and ImpairmentWritedown
47.10M40.00M146.90M123.60M40.00M220.20M
Cash from Restructuring
Other non-cash itemsOther Non-Cash
-6.90M24.60M-20.90M-12.50M9.40M7.90M-26.90M7.20M8.20M16.70M9.70M11.10M-12.50M18.40M7.00M-4.20M
Change in Working Capital
0.10M-13.00M-19.50M-7.20M-12.30M6.20M-1.50M-19.50M3.20M-4.20M-0.90M1.00M-17.30M-28.60M4.70M-7.90M-2.70M-18.10M0.40M-9.40M
Change in ReceivablesChange Receivables
-6.80M57.80M19.90M5.30M1.10M77.50M46.80M-1.30M18.20M55.00M-23.00M-47.30M-105.90M43.70M24.90M-13.20M-32.40M117.90M10.20M19.90M
Change in InventoryChange Inventory
6.60M24.00M61.80M65.30M62.30M32.80M80.90M76.00M99.30M69.50M94.20M41.20M51.20M0.10M-41.60M1.80M-11.00M1.60M23.50M24.60M
Change in Accrued ExpensesChange Accrued Exp.
31.10M-109.20M27.50M26.00M34.30M-45.20M121.40M36.40M33.40M-89.10M151.80M29.90M-3.10M-103.40M103.70M226.10M168.70M-347.10M123.70M67.20M
Change in TaxesChange Taxes
33.00M82.90M-33.20M-40.90M-14.40M87.20M-56.20M75.30M-112.10M-263.10M-106.90M671.80M-488.50M51.20M-240.40M-10.20M57.60M41.90M12.00M43.80M
Change in Other Operating AssetsOther Assets Change
-6.40M-1.70M-24.00M5.40M20.20M23.80M133.60M18.20M16.10M-27.10M-13.00M12.70M-3.60M-10.60M13.90M14.20M-2.10M8.70M-29.50M22.80M
Change in Other Operating LiabilitiesOther Liabilities Change
-10.10M-10.00M-9.70M-16.40M-8.90M29.30M-43.80M-11.50M-7.00M-5.20M-6.60M-12.50M-12.50M-36.70M-12.50M-12.50M-14.80M-50.00M
Other Working Capital ChangesOther WC Changes
0.10M-13.00M-19.50M-7.20M-12.30M6.20M-1.50M-19.50M3.20M-4.20M-0.90M1.00M-17.30M-28.60M4.70M-7.90M-2.70M-18.10M0.40M-9.40M
Cash from OperationsCash from Ops.
373.60M293.30M332.20M309.90M282.80M314.10M33.60M411.50M136.60M-53.50M371.50M351.80M-127.50M280.40M290.20M573.70M450.90M43.80M651.90M570.30M
Investing Activities
Capital ExpendituresCapex
89.80M72.70M43.10M59.90M68.90M61.50M47.90M55.30M88.30M65.30M85.40M51.90M49.80M56.00M49.30M57.50M97.40M64.90M66.90M63.60M
Sales of Property, Plant and EquipmentPP&E (Sale)
Change in Property, Plant and EquipmentChange in PP&E
-89.80M-72.70M-43.10M-59.90M-68.90M-61.50M-47.90M-55.30M-88.30M-65.30M-85.40M-51.90M-49.80M-56.00M-49.30M-57.50M-97.40M-64.90M-66.90M-63.60M
Change in IntangiblesChange Intangibless
13.10M0.20M20.00M5.40M4.60M
Acquisitions
7.40M55.50M52.10M2.00M15.00M30.80M10.80M6.00M32.30M57.40M3.00M62.30M4.10M20.50M6.30M7.10M4.30M
Divestments
-3,927.40M
Net of Acquisitions & DivestmentsNet Acquisitions
-7.40M-55.50M-52.10M-2.00M-15.00M-30.80M-10.80M-6.00M-32.30M-3,984.80M-3.00M-62.30M-4.10M-20.50M-6.30M-7.10M-4.30M
Purchase of InvestmentsInvestments Purchased
1,054.30M202.10M92.90M293.30M81.00M15.70M6.60M9.60M43.60M2.60M13.30M539.20M390.70M647.30M630.30M1,030.80M826.70M653.60M564.10M676.90M
Sale and Maturity of InvestmentsInvestments Sold
197.10M502.00M359.60M224.00M273.50M263.90M134.10M180.40M137.40M166.60M247.00M175.90M268.10M845.60M626.10M691.90M714.50M722.60M448.50M492.50M
Other Investing Activities (as filed)Other investing (as filed)
-7.50M2.30M-38.50M-20.20M-6.70M-16.90M-9.20M-26.50M-6.60M-4.80M-17.50M-9.20M-44.10M-17.70M-56.30M-27.30M-47.00M-55.50M-5.00M-4.10M
Cash from Investing ActivitiesCash from Investing
-965.90M229.50M129.60M-201.50M94.70M0.50M70.20M89.00M14.10M63.10M124.80M2,701.70M-576.70M85.30M-172.10M-427.80M-198.30M-92.80M-193.20M-256.40M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
0.10M0.10M0.10M
Net Long-Term Debt Issued (Repaid)Net LT Debt
-0.10M-0.10M-0.10M
Short-Term Debt issuancesST Debt Issuance
Short-Term Debt repaymentsST Debt Repayment
Net Short-Term Debt Issued (Repaid)Net ST Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.10M-0.10M-0.10M
Change in Capital Stock
Common Stock IssuedStock Issued
33.90M37.50M49.00M32.40M27.50M41.90M60.80M34.00M33.20M62.10M54.30M34.50M28.60M49.90M57.20M34.70M32.30M68.90M53.80M36.50M
Shares Repurchased
96.50M405.60M355.10M100.40M866.00M249.30M7.50M174.40M448.40M0.20M158.10M901.00M100.10M258.60M5.50M588.70M40.60M421.80M153.30M138.90M
Net Shares Issued and RepurchasedNet Shares Issued
-62.60M-368.10M-306.10M-68.00M-838.50M-207.40M53.30M-140.40M-415.20M61.90M-103.80M-866.50M-71.50M-208.70M51.70M-554.00M-8.30M-352.90M-99.50M-102.40M
Net Equity Issued and RepurchasedNet Equity Issued
-62.60M-368.10M-306.10M-68.00M-838.50M-207.40M53.30M-140.40M-415.20M61.90M-103.80M-866.50M-71.50M-208.70M51.70M-554.00M-8.30M-352.90M-99.50M-102.40M
Other financing activities (as filed)
0.70M-2.00M-1.90M0.10M0.80M-1.20M-2.90M2.00M-0.20M7.20M-10.20M0.10M0.70M1.00M-236.10M-3.10M1.70M-0.80M1.60M
Cash from Financing ActivitiesCash from Financing
-62.00M-368.10M-308.10M-69.90M-838.40M-206.60M52.10M-143.30M-413.20M61.70M-96.60M-976.70M28.60M-258.00M52.70M-740.10M-11.40M-451.20M-0.30M-100.80M
Additional items
Exchange Rate EffectFX Effect
1.80M13.20M13.90M10.30M-18.20M-4.20M15.20M9.20M-3.40M9.70M29.40M-51.50M51.00M-17.70M-29.60M-1.00M3.50M8.20M3.80M-10.40M
Change in Cash
-652.50M167.90M167.60M48.80M-479.10M103.80M171.10M366.40M-265.90M81.00M429.10M2,025.30M-624.60M90.00M141.20M-595.20M244.70M-492.00M462.20M202.70M
Beginning Cash Balance
Ending Cash Balance
867.40M1,035.30M1,202.90M1,251.70M772.60M876.40M1,047.50M1,413.90M1,148.00M1,229.00M1,658.10M3,683.40M3,058.80M3,148.80M3,290.00M2,694.80M2,939.50M2,447.50M2,909.70M3,112.40M
Free Cash FlowFCF
283.80M220.60M289.10M250.00M213.90M252.60M-14.30M356.20M48.30M-118.80M286.10M299.90M-177.30M224.40M240.90M516.20M353.50M-21.10M585.00M506.70M
Net Cash FlowNCF
-654.30M154.70M153.70M38.50M-460.90M108.00M155.90M357.20M-262.50M71.30M399.70M2,076.80M-675.60M107.70M170.80M-594.20M241.20M-500.20M458.40M213.10M
Income Taxes PaidTaxes Paid

Edwards Lifesciences Cash Flow Statement API

Pull Edwards Lifesciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=EW&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY